{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:30:38Z","timestamp":1786480238343,"version":"build-2736575974"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2025,1]]},"abstract":"\n Key Points<\/jats:title>\n \n \n \n Incident dialysis patients show a high prevalence of pruritus during the first year of dialysis, with pruritus being either persistent or fluctuating.<\/jats:p>\n <\/jats:list-item>\n \n Medical treatment for pruritus does not improve quality of life within the 25% of patients with pruritus receiving it.<\/jats:p>\n <\/jats:list-item>\n \n High prevalence, negative effect, and low treatment rate of pruritus urges for more awareness, for instance, by the means of patient reported outcomes.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n Pruritus is common in dialysis patients and associated with impaired health-related quality of life (HRQoL) and sleep disturbances. Its pathophysiology remains unclear, resulting in limited treatment options and lack of treatment guidelines. The exact trajectory of pruritus after dialysis initiation, nor the state of current medical treatment, has been studied.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n Incident dialysis patients (\n N<\/jats:italic>\n =1438) included in the Dutch nocturnal and home dialysis study to improve clinical outcomes were studied. Outcome parameters were prevalence of pruritus, severity of pruritus, and the use of antipruritic medication, repeatedly measured during the first year of dialysis. Associations between treatment, pruritus, and quality of life were longitudinally studied using linear mixed models.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The prevalence of pruritus ranged from 50.5% to 56.6% during the first year of dialysis. Throughout the year, approximately 35% experienced persistent pruritus and 40% fluctuating pruritus. During follow-up, 21.5%\u201326.5% received medical treatment for pruritus. Emollients were associated with more severe pruritus (adjusted\n \u03b2<\/jats:italic>\n =0.31; 95% confidence interval [CI], 0.15 to 0.48); the remaining treatments did not show any association. Pruritus was significantly associated with lower physical and mental HRQoL (adjusted\n \u03b2<\/jats:italic>\n =\u22122.04; 95% CI, \u22122.78 to \u22121.30 and\n \u03b2<\/jats:italic>\n =\u22121.73; 95% CI, \u22122.51 to \u22120.94, respectively), irrespective of treatment.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n During the first year of dialysis, pruritus is highly prevalent, predominantly fluctuating, and associated with impaired HRQoL. The minority of patients received medical treatment; in our study, current treatment was not associated with an improvement of pruritus. These results highlight the need for more awareness among clinicians and for the development of effective treatment options.<\/jats:p>\n <\/jats:sec>","DOI":"10.34067\/kid.0000000615","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T12:19:59Z","timestamp":1729081199000},"page":"95-104","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and Association of Pruritus and its Current Treatment during the First Year of Dialysis"],"prefix":"10.34067","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1628-2503","authenticated-orcid":false,"given":"Thomas S.","family":"van Lieshout","sequence":"first","affiliation":[{"name":"Department of Nephrology, Amsterdam UMC location Vrije Universiteit Amsterdam, Research institute Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands"},{"name":"Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands"},{"name":"Amsterdam Cardiovascular Sciences, Diabetes and Metabolism, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3271-5572","authenticated-orcid":false,"given":"Esmee","family":"Driehuis","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Amsterdam UMC location Vrije Universiteit Amsterdam, Research institute Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands"},{"name":"Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alferso C.","family":"Abrahams","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violette","family":"de Ruijter","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Amsterdam UMC location Vrije Universiteit Amsterdam, Research institute Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3150-2066","authenticated-orcid":false,"given":"Sanne J.","family":"de Lange","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6877-522X","authenticated-orcid":false,"given":"Anna A.","family":"Bonenkamp","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Amsterdam UMC location Vrije Universiteit Amsterdam, Research institute Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands"},{"name":"Department of Internal Medicine, Jeroen Bosch Hospital, Hertogenbosch, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9596-8529","authenticated-orcid":false,"given":"An S.","family":"De Vriese","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium"},{"name":"Department of Internal Medicine, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5734-4566","authenticated-orcid":false,"given":"Robin W.M.","family":"Vernooij","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands"},{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3088-4583","authenticated-orcid":false,"given":"Patrick M.J.H.","family":"Kemperman","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Amsterdam University Medical Center (UMC), Amsterdam, The Netherlands"},{"name":"Department of Dermatology, Dijklander Hospital, Purmerend, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7580-0684","authenticated-orcid":false,"given":"Thomas","family":"Rustemeyer","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Amsterdam University Medical Center (UMC), Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8079-0166","authenticated-orcid":false,"given":"Frans J.","family":"van Ittersum","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Amsterdam UMC location Vrije Universiteit Amsterdam, Research institute Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands"},{"name":"Amsterdam Cardiovascular Sciences, Diabetes and Metabolism, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6018-4679","authenticated-orcid":false,"given":"Erik L.","family":"Penne","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5871-4952","authenticated-orcid":false,"given":"Brigit C.","family":"van Jaarsveld","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Amsterdam UMC location Vrije Universiteit Amsterdam, Research institute Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands"},{"name":"Amsterdam Cardiovascular Sciences, Diabetes and Metabolism, Amsterdam, The Netherlands"},{"name":"Nephrocare Diapriva Dialysis Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the DOMESTICO study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"issue":"2","key":"B1-20250130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archderm.1932.01450030311010","article-title":"Skin diseases in nonsurgical renal disease","volume":"26","author":"Chargin","year":"1932","journal-title":"Arch Derm Syphilol."},{"issue":"8","key":"B2-20250130","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1111\/jdv.16133","article-title":"The first mention of itch in history? When Egyptologists scratch their heads","volume":"34","author":"Mueller","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"1","key":"B3-20250130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/j.ajkd.2007.03.010","article-title":"An update on pruritus associated with CKD","volume":"50","author":"Patel","year":"2007","journal-title":"Am J Kidney Dis."},{"issue":"12","key":"B4-20250130","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.2215\/CJN.03280317","article-title":"International comparisons of prevalence, awareness, and treatment of pruritus in people on hemodialysis","volume":"12","author":"Rayner","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"B5-20250130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.xkme.2020.08.011","article-title":"Self-reported pruritus and clinical, dialysis-related, and patient-reported outcomes in hemodialysis patients","volume":"3","author":"Sukul","year":"2021","journal-title":"Kidney Med."},{"issue":"7","key":"B6-20250130","first-page":"e5178","article-title":"Uremic pruritus: prevalence and impact on quality of life and depressive symptoms in hemodialysis patients","volume":"11","author":"Satti","year":"2019","journal-title":"Cureus."},{"key":"B7-20250130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/IJNRD.S108045","article-title":"Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges","volume":"10","author":"Shirazian","year":"2017","journal-title":"Int J Nephrol Renovasc Dis."},{"issue":"9","key":"B8-20250130","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfac022","article-title":"Itching in dialysis patients: impact on health-related quality of life and interactions with sleep problems and psychological symptoms-results from the RENINE\/PROMs registry","volume":"37","author":"van der Willik","year":"2022","journal-title":"Nephrol Dial Transplant."},{"issue":"6","key":"B9-20250130","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1053\/j.ajkd.2023.04.008","article-title":"Pruritus in hemodialysis patients: longitudinal associations with clinical and patient-reported outcomes","volume":"82","author":"Sukul","year":"2023","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B10-20250130","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2340\/00015555-1749","article-title":"Uraemic pruritus markedly affects the quality of life and depressive symptoms in haemodialysis patients with end-stage renal disease","volume":"94","author":"Suse\u0142","year":"2014","journal-title":"Acta Derm Venereol."},{"issue":"1","key":"B11-20250130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.23876\/j.krcp.21.189","article-title":"Uremic pruritus: pathophysiology, clinical presentation, and treatments","volume":"42","author":"Ko","year":"2023","journal-title":"Kidney Res Clin Pract."},{"issue":"suppl 3","key":"B12-20250130","doi-asserted-by":"crossref","first-page":"i23","DOI":"10.1093\/ckj\/sfab200","article-title":"Unravelling the pathophysiology of chronic kidney disease-associated pruritus","volume":"14","author":"Schricker","year":"2021","journal-title":"Clin Kidney J."},{"issue":"12","key":"B13-20250130","first-page":"CD011393","article-title":"Interventions for itch in people with advanced chronic kidney disease","volume":"12","author":"Hercz","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"issue":"5","key":"B14-20250130","doi-asserted-by":"crossref","first-page":"e12683","DOI":"10.1111\/dth.12683","article-title":"Treatments of uremic pruritus: a systematic review","volume":"31","author":"Malekmakan","year":"2018","journal-title":"Dermatol Ther."},{"issue":"1","key":"B15-20250130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nefroe.2022.02.004","article-title":"Pruritus in dialysis patients. Review and new perspectives","volume":"42","author":"Santos-Alonso","year":"2022","journal-title":"Nefrolog\u00eda (Engl Ed)."},{"issue":"5","key":"B16-20250130","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2017.05.018","article-title":"Treatment of uremic pruritus: a systematic review","volume":"70","author":"Simonsen","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B17-20250130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12882-019-1526-4","article-title":"Dutch nOcturnal and hoME dialysis Study to Improve Clinical Outcomes (DOMESTICO): rationale and design","volume":"20","author":"van Eck van der Sluijs","year":"2019","journal-title":"BMC Nephrol."},{"issue":"4","key":"B18-20250130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol."},{"issue":"3","key":"B19-20250130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpainsymman.2003.07.004","article-title":"Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis Symptom Index","volume":"27","author":"Weisbord","year":"2004","journal-title":"J Pain Symptom Manage."},{"issue":"5","key":"B20-20250130","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3390\/diagnostics12051108","article-title":"Uremic pruritus: from diagnosis to treatment","volume":"12","author":"Cheng","year":"2022","journal-title":"Diagnostics (Basel)."},{"issue":"1","key":"B21-20250130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.nephro.2020.09.006","article-title":"Efficacy of uremic pruritus treatment in patients undergoing hemodialysis, a network meta-analysis for randomized clinical trials","volume":"17","author":"Feng","year":"2021","journal-title":"Nephrol Ther."},{"issue":"3","key":"B22-20250130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care."},{"issue":"4","key":"B23-20250130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11136-009-9455-5","article-title":"Normative data of the SF-12 health survey with validation using postmyocardial infarction patients in the Dutch population","volume":"18","author":"Mols","year":"2009","journal-title":"Qual Life Res."},{"issue":"1","key":"B24-20250130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ije\/dyh299","article-title":"Regression to the mean: what it is and how to deal with it","volume":"34","author":"Barnett","year":"2005","journal-title":"Int J Epidemiol."},{"issue":"8","key":"B25-20250130","doi-asserted-by":"crossref","first-page":"e13145","DOI":"10.1111\/eci.13145","article-title":"Understanding of interaction (subgroup) analysis in clinical trials","volume":"49","author":"Brankovic","year":"2019","journal-title":"Eur J Clin Invest."},{"issue":"9","key":"B26-20250130","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jclinepi.2013.03.017","article-title":"Multiple imputation of missing values was not necessary before performing a longitudinal mixed-model analysis","volume":"66","author":"Twisk","year":"2013","journal-title":"J Clin Epidemiol."},{"issue":"4","key":"B27-20250130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/biostatistics\/kxx045","article-title":"Methods for handling longitudinal outcome processes truncated by dropout and death","volume":"19","author":"Wen","year":"2018","journal-title":"Biostatistics."},{"issue":"8","key":"B28-20250130","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2215\/CJN.00100110","article-title":"A longitudinal study of uremic pruritus in hemodialysis patients","volume":"5","author":"Mathur","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"issue":"7","key":"B29-20250130","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/jdv.15483","article-title":"The course of chronic itch in hemodialysis patients: results of a 4-year follow-up study of GEHIS (German Epidemiological Hemodialysis Itch Study)","volume":"33","author":"Plewig","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"7","key":"B30-20250130","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/ckj\/sfad032","article-title":"Moderate-to-severe pruritus in untreated or non-responsive hemodialysis patients: results of the French prospective multicenter observational study Pruripreva","volume":"16","author":"Lanot","year":"2023","journal-title":"Clin Kidney J."},{"issue":"8","key":"B31-20250130","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ckj\/sfad066","article-title":"A phase IV, randomised, double-blind, controlled, parallel group trial to evaluate the effectiveness and safety of Balneum Plus versus emollient in the treatment of chronic kidney disease-associated pruritus in haemodialysis patients","volume":"16","author":"Nevols","year":"2023","journal-title":"Clin Kidney J."},{"issue":"5","key":"B32-20250130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1526-0968.2004.00175.x","article-title":"Effect of skin care with an emollient containing a high water content on mild uremic pruritus","volume":"8","author":"Okada","year":"2004","journal-title":"Ther Apher Dial."},{"issue":"7","key":"B33-20250130","first-page":"e42587","article-title":"Management of uremic xerosis and chronic kidney disease (CKD)-associated pruritus (CKD-aP) with topical preparations: a systematic review and implications in the Indian context","volume":"15","author":"Verma","year":"2023","journal-title":"Cureus."},{"key":"B34-20250130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40697-016-0107-8","article-title":"Gabapentin for uremic pruritus in hemodialysis patients: a qualitative systematic review","volume":"3","author":"Lau","year":"2016","journal-title":"Can J Kidney Health Dis."},{"issue":"1","key":"B35-20250130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.ajkd.2016.07.031","article-title":"Sleep disorders, restless legs syndrome, and uremic pruritus: diagnosis and treatment of common symptoms in dialysis patients","volume":"69","author":"Scherer","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"12","key":"B36-20250130","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1007\/s11136-016-1340-4","article-title":"Health-related quality of life in haemodialysis patients suffering from chronic itch: results from GEHIS (German Epidemiology Haemodialysis Itch Study)","volume":"25","author":"Weiss","year":"2016","journal-title":"Qual Life Res."},{"issue":"3","key":"B37-20250130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/13651501.2014.907919","article-title":"Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety","volume":"18","author":"Ozdemir","year":"2014","journal-title":"Int J Psychiatry Clin Pract."},{"issue":"3","key":"B38-20250130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.smrv.2013.07.005","article-title":"A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions","volume":"18","author":"Roth","year":"2014","journal-title":"Sleep Med Rev."},{"issue":"9","key":"B39-20250130","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-4362.1979.tb05011.x","article-title":"Ultraviolet phototherapy of uremic pruritus","volume":"18","author":"Gilchrest","year":"1979","journal-title":"Int J Dermatol."},{"issue":"1","key":"B40-20250130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-91-1-17","article-title":"Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action","volume":"91","author":"Gilchrest","year":"1979","journal-title":"Ann Intern Med."},{"issue":"1","key":"B41-20250130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s41687-021-00404-z","article-title":"Psychometric validation and meaningful change thresholds of the Worst Itching Intensity Numerical Rating Scale for assessing itch in patients with chronic kidney disease-associated pruritus","volume":"5","author":"Vernon","year":"2021","journal-title":"J Patient Rep Outcomes."},{"issue":"3","key":"B42-20250130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1912770","article-title":"A phase 3 trial of difelikefalin in hemodialysis patients with pruritus","volume":"382","author":"Fishbane","year":"2020","journal-title":"N Engl J Med."},{"issue":"4","key":"B43-20250130","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/10600280221115889","article-title":"Difelikefalin: a new \u03ba-opioid receptor agonist for the treatment of hemodialysis-dependent chronic kidney disease-associated pruritus","volume":"57","author":"Fugal","year":"2023","journal-title":"Ann Pharmacother."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:59:27Z","timestamp":1786478367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000615"}},"subtitle":["A Dutch Nocturnal and Home Dialysis Study to Improve Clinical Outcomes Study"],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000615","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"2024-07-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}